L879-0182 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-2-[(2H-1,3-benzodioxol-5-yl)formamido]-4-methylpentanamide

L879-0182 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-2-[(2H-1,3-benzodioxol-5-yl)formamido]-4-methylpentanamide
L879-0182 Screening compound: N-(1H-1,3-benzodiazol-2-yl)-2-[(2H-1,3-benzodioxol-5-yl)formamido]-4-methylpentanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound L879-0182
N-(1H-1,3-benzodiazol-2-yl)-2-[(2H-1,3-benzodioxol-5-yl)formamido]-4-methylpentanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L879-0182

Molecular Formula

C21H22N4O4 (C21 H22 N4 O4)

Compound Name

N-(1H-1,3-benzodiazol-2-yl)-2-[(2H-1,3-benzodioxol-5-yl)formamido]-4-methylpentanamide

IUPAC name

N-(1H-13-benzodiazol-2-yl)-2-[(2H-13-benzodioxol-5-yl)formamido]-4-methylpentanamide

SMILES

CC(C)CC(C(Nc1nc(cccc2)c2[nH]1)=O)NC(c(cc1)cc2c1OCO2)=O

InChI

InChI=1S/C21H22N4O4/c1-12(2)9-16(20(27)25-21-23-14-5-3-4-6-15(14)24-21)22-19(26)13-7-8-17-18(10-13)29-11-28-17/h3-8,10,12,16H,9,11H2,1-2H3,(H,22,26)(H2,23,24,25,27)/t16-/m0/s1

InChI Key

FHOGLTRILLYDDB-INIZCTEOSA-N

MDL Number (MFCD)

MFCD27483922

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

394.43

Hydrogen Bond Acceptors Count

7.00

Hydrogen Bond Donors Count

3.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.197

Distribution Coefficient, logD

3.197

Water Solubility, LogSw

-3.61

Polar Surface Area

85.186

Acid Dissociation Constant (pKa)

11.39

Base Dissociation Constant (pKb)

2.74

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

28.60

L879-0182 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

Chelators targeting matrix metalloproteinases library (8930 compounds)

SH2 Library (10483 compounds)

Serine Proteases Inhibitors Library (32732 compounds)

SmartTM Library (51161 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Cardiovascular
  • Cancer
  • Endocrine
  • Infections
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Cardiovascular
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Proteases
  • Proteases
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with L879-0182 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L879-0182?
Check Price and Availability of L879-0182, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L879-0182 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L879-0182
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L879-0182
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L879-0182 available by request